Início › Doenças Pulmonares Intersticiais › Nova York
Ensaios clínicos de Doenças Pulmonares Intersticiais em Nova York
20 estudos para Doenças Pulmonares Intersticiais estão buscando participantes em locais em Nova York.
Cidades em Nova York
Texto oficial do estudo (Inglês)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Weill Cornell Medicine-New York-60569, New York
- Columbia University Medical Center-New York Presbyterian Hospital, New York
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Weill Cornell Medicine-New York-60569, New York
RecrutandoFase 3
Idades 40 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA005, New York
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medicine, New York
RecrutandoFase 2
Idades de 18 a 80 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05798923A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), East White Plains
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07323732A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, New York
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, New York
- GSK Investigational Site, New York
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Icahn School of Medicine at Mount Sinai, New York
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Buffalo, Buffalo
- Weill Cornell University Medical College, New York
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- NYU Langone Health, New York
- University of Rochester Medical Center, Rochester
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Northwell Health, New Hyde Park
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital - Weill Cornell Medicine, New York
- e mais 1
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Weill Cornell Medicine, New York
RecrutandoEstudo observacional
Idades de 18 a 80 · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06855329Platform Clinical Study for Conquering Scleroderma
- Northwell Health, Great Neck
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Columbia University Irving Medical Center, New York
- University of Rochester, Rochester
RecrutandoFase 2/3
Idades de 18 a 75 · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Weill Medical College of Cornell University, New York
RecrutandoEstudo observacional
Idades 21 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT01915511The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
- University of Rochester Medical Center, Rochester
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 24 de jul. de 2026 · NCT07561034Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Northwell Health, New Hyde Park
- Weill Cornell Medicine, New York-Presbyterian Hospital, New York
- Stony Brook Advanced Specialty Care, Stony Brook
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT05943535Cough Capture as a Portal Into the Lung
- Albert Einstein College of Medicine, The Bronx
RecrutandoEstudo observacional
Idades 21 e acima · Todos os sexos · Atualizado em 13 de jan. de 2026 · NCT05854563Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, New York
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de mai. de 2025 · NCT05892614Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.